Spectral sensing of ablation
AssigneeBiosense Webster (Israel) Ltd.
InventorsAssaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Vadim GLINER
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiosense Webster (Israel) Ltd.
InventorsAssaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Vadim GLINER
Estimating the term…
A method for tissue assessment includes ablating tissue at a site within a body of a living subject using an invasive probe applied to the site. At a first stage in ablation of the tissue, first measurements are made of scattered light intensities from the site at a plurality of different wavelengths. At a second stage in the ablation of the tissue, subsequent to the first stage, second measurements are made of the scattered light intensities from the site at the plurality of different wavelengths. Progress of the ablation is assessed by computing different, respective measures of change in the scattered light intensities at the different wavelengths occurring between the first and second measurements, and comparing the respective measures.
A method for tissue assessment, comprising:
The method according to claim 8, in which the third wavelength is between about 670 nm and about 710 nm.
A medical apparatus, comprising:
Dependencies are inferred from the claim text.